[go: up one dir, main page]

WO1992017778A1 - Dispositifs analytiques - Google Patents

Dispositifs analytiques Download PDF

Info

Publication number
WO1992017778A1
WO1992017778A1 PCT/GB1992/000576 GB9200576W WO9217778A1 WO 1992017778 A1 WO1992017778 A1 WO 1992017778A1 GB 9200576 W GB9200576 W GB 9200576W WO 9217778 A1 WO9217778 A1 WO 9217778A1
Authority
WO
WIPO (PCT)
Prior art keywords
enclosure
electrode assembly
reactor
reactor according
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1992/000576
Other languages
English (en)
Inventor
Robert Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP4506950A priority Critical patent/JPH06506144A/ja
Publication of WO1992017778A1 publication Critical patent/WO1992017778A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3272—Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/06—Auxiliary integrated devices, integrated components
    • B01L2300/0627—Sensor or part of a sensor is integrated
    • B01L2300/0645—Electrodes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0809—Geometry, shape and general structure rectangular shaped
    • B01L2300/0825—Test strips
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces

Definitions

  • These devices are preferably of a self-contained form, typically requiring only the application of a sample of a body fluid such as urine or blood, for example.
  • the devices are mostly of a qualitative or semi-qualitative form requiring some ability on the part of the user to interpret the analytical result. Because the user is commonly not skilled for this last purpose, and in fact is often a lay individual, the user-dependent nature of the devices makes them less than completely satisfactory.
  • the present invention particularly concerns quantitative devices of a two-part form involving a reusable instrument co-operable with disposable analytical reactors. More particularly, the invention concerns such two-part devices in which the reactor involves a body of capillary material carrying at least one immobilised reagent and engaging an electrode assembly connectable with an associated instrument.
  • the reactor involves a body of capillary material carrying at least one immobilised reagent and engaging an electrode assembly connectable with an associated instrument.
  • a sample for analysis, and liquid to mobilise the reagent or reagents are applied to the capillary body and the resultant reaction influences the electrode assembly in a manner dependent on the sample to provide a related quantitative output from the instrument.
  • Such a device and use offers several advantages but, as so far proposed, also suffers from some disadvantages associated with the capillary body.
  • reagent can be mobilised in an undesirable manner to create areas of significantly different reagent concentrations.
  • Another disadvantage is that, if the mobilising liquid is applied by dipping the body into a liquid reservoir, which is attractive for its simplicity, reagent can be leached from the body into the reservoir and impair the desired reaction.
  • a further disadvantage is that the liquid contents of the body can be adversely affected by movement of the body such as occur, for example, with dipping.
  • An object of the present invention is to reduce these disadvantages and, to this end, the invention provides a disposable reactor for use with a co-operable instrument to form a quantitative analytical device, the reactor comprising a body of capillary material, a liquid-impermeable enclosure housing the capillary body and having an opening for application of liquid to the body, at least one reagent immobilised within the enclosure, and an electrode assembly passing through the enclosure, with one portion of the assembly extending within the enclosure to engage the capillary body and another portion of the assembly extending outside the enclosure, remotely from the enclosure opening, for connection with the associated instrument.
  • a reagent can be immobilised in the enclosure by impregnation or other incorporation in the capillary body and/or by deposition on or other incorporation in the interior of the enclosure.
  • the enclosure and the housed capillary body are of an elongate form with the opening at one end of the enclosure and the electrode assembly passing through the opposite end.
  • a form suitably involves a strip base for the enclosure, an electrode assembly extending longitudinally along one side face of the base, a capillary body also of strip form and located on the base as well as one end portion, but not the other, of the electrode assembly, and an enclosure cover extending transversely over the body and connected with the base while leaving the electrode assembly other end portion exposed.
  • the electrode assembly can in fact be directly covered with a layer of electrically insulating material over much of its length provided that it is exposed towards its ends respectively for operable engagement with the capillary body and an associated instrument.
  • Figure 1 schematically illustrates in exploded manner one form of a reactor according to the invention together with an associated instrument.
  • Figure 2 illustrates the results obtained for one form of ana tical assay effected with a particular embodiment of the reactor of Figure 1 ,
  • FIG. 3 illustrates the reactions involved in another form of assay
  • Figure 4 illustrates results obtained for the assay of Figure 3 with another reactor embodiment
  • Figures 5 and 6 respectively illustrate yet another assay and results associated with a further reactor embodiment.
  • FIG. 1 the reactor and associated instrument are denoted general ly at 10 and 20.
  • the reactor 10 has a base 11 of strip form made of material which is liquid impermeable and electrically insulating.
  • An electrode assembly consisting of two mutually spaced parallel electrodes 12 are mounted longitudinally on one face of the base and have an intermediate portion of their length covered by a layer 13 of further impermeable insulating material to leave the electrodes exposed at their extremities.
  • a body 14 of capillary material is, in turn, located to cover the exposed electrodes at one extremity.
  • the body 14 is itself covered by a further layer 15 of impermeable insulating material which extends transversely round the body to connect with the base, while leaving exposed the end of the body remote from layer 13.
  • at least one reagent 16 is deposited on part of the base covered by the body.
  • the base was made of polyvinylchloride (PVC).
  • the electrodes were applied by screen coating with one, the working electrode, being of carbon and the other, the reference or counter electrode, being of silver, surface treated to provide a coating of silver chloride.
  • the capillary body was made of 0.5 mm thick PVA foam (Grade PRO/800; Prosthex Ltd., Surrey, England).
  • the layers 13 and 15 were made of adhesive electrical insulating (PVC) tape and polymethylmethacr late (Perspex), respectively. Reagent compositions differed between the embodiments for the purposes of respectively different analyses.
  • the instrument 20 can be of any suitable form adapted for cooperation with the reactor. Clearly it will have a socket 21 or other connector for mutual engagement or other working cooperation with the exposed electrode assembly portion of the reactor.
  • the instrument includes electronic components operable to respond to a representative potential difference set up between the reactor electrodes under the influence of the analytical reaction and to indicate that difference, or a resultant current flow, as a quantified output at a visual display 22.
  • the instrument can also include components operable to render the former fully operable in response to use of a reactor connected therewith, such as by reaction to liquid application.
  • other components can effect temperature compensation, switch between a range of operational modes in response to differential coding incorporated in reactors of different analytical type, and effect other useful functions.
  • Assay 1 This assay was carried out for glucose.
  • the carbon working electrode of the reactor was doped with 1 ,1 '-dimethyl- ferrocene and had the enzyme glucose oxidase immobilised on to it.
  • Glucose solutions were made up in phosphate buffered saline and allowed to stand overnight.
  • Assays were carried out by touching the surface of the glucose solution with the opening end of the reactor. This caused the solution to wick up the capillary body and come into contact with the electrodes to provide a response which was almost instantaneous.
  • This response was in the form of a potential difference across the reactor and this was applied to an instrument in the form of a 4700 ⁇ F capacitor deployed to integrate the relevant voltage for two minutes.
  • Such an embodiment can be useful to carry out glucose and other determinations in physiological fluids like blood.
  • a filter in the reactor enclosure, between the capillary body and opening, as indicated at 17 in Figure 1.
  • This filter is effective to remove unwanted materials such as red blood cells from the incoming sample.
  • Such an embodiment may usefully be integrated with a lance or other implement useful in providing a blood or other sample. Similar considerations might also apply to other materials for analysis, such as certain foods. These, for example jam, are often viscous and not amenable to normal analytical techniques.
  • a filter into the reactor, it is possible selectively to isolate the free-flowing component and carry out an assay on this.
  • Assay 2 This assay was carried out for ethanol . It is described here as an example of an analytical reaction that involves a soluble co-enzyme (NAD).
  • the reactor embodiment involved the enzymes alcohol dehydrogenase (10 mg ml -1 ) and diaphorase (2 mg ml -1 ), the co-enzyme NAD (10 mg ml -1 ), and the electron acceptor potassium ferricyanide (40 mg m1 -1 ), immobilised in 1:1 polyvinyl- pyrrolidone (made up with 0.2 M pyrophosphate buffer, pH 9.0) on the reactor base. When an aqueous solution of ethanol was drawn into the reactor, the reagents were dissolved.
  • Ferricyanide is reduced to ferrocyanide as shown in Figure 3. This was detected electrochemical ly at the working electrode. Again, the voltage resulting from the analytical reaction was used to charge up a capacitor, the voltage across the capacitor after two minutes was plotted against the concentration of ethanol, and the resultant operational characteristic is shown in Figure 4. Assay 3. This assay was carried out for aluminium and it is described here as an example of an analytical reaction that involves enzyme inhibition.
  • the reactor embodiment involved the enzymes hexokinase (40 ⁇ g ml " , diaphorase (2 mg ml -1 ), and glucose 6-phosphate-dehydrogenase ( 20 ⁇ l ml -1 ) and the co-enzyme NADP (lO g ml -1 ), immobilised in 1:1 polyvinylpyrrol idone (made up in 1.25 M imidazole buffer, pH 6.9, containing 1 mM magnesium chloride), on the reactor base.
  • hexokinase 40 ⁇ g ml "
  • diaphorase 2 mg ml -1
  • glucose 6-phosphate-dehydrogenase 20 ⁇ l ml -1
  • NADP co-enzyme NADP
  • the substrates adenosine triphosphate (15 mg ml -1 ) and glucose (50 mg ml -1 ) and the electron acceptor ferricyanide (80 mg ml -1) were immobilised in 1:1 polyvinylpyrrolidone ( made up in 1.25 M imidazole buffer, pH 6.9, that contained 1 mM magnesium chloride) on the inner face of the enclosure.
  • polyvinylpyrrolidone made up in 1.25 M imidazole buffer, pH 6.9, that contained 1 mM magnesium chloride
  • the reagents dissolve in it and ferricyanide is reduced to ferrocyanide as shown in Figure 5.
  • the reaction was allowed to proceed for five minutes.
  • Ferrocyanide was detected electrochemical ly with the resultant voltage being applied to charge up a capacitor.
  • the integrated capacitor voltage after one minute was plotted against the concentration of aluminium to give a characteristic as shown in Figure 6.
  • the reactor can accommodate a sequence of reactions involving the same sample, with an associated instrument giving individual and/or, if appropriate, composite quantitative results for the respective analytical reactions.
  • the reactor base can have the appropriate reagents applied thereto as respective transverse bands in a successively spaced assay along the base so that the reagents are mobilised in sequence as liquid is drawn into the capillary body.
  • plural capillary body channels leading to a common site can be provided, as proposed in Patent Specification WO 90/11519.
  • an alternative reactor form involves a compressed or otherwise liquid-expansible capillary body.
  • a compressed or otherwise liquid-expansible capillary body can expand when activated by the application of liquid to trap a thin film of the liquid against the associated electrodes.
  • such an expansion can be used to close off the enclosure adjacent the opening to prevent, or at least reduce, outward leaching.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Clinical Laboratory Science (AREA)
  • Biotechnology (AREA)
  • Electrochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Devices For Use In Laboratory Experiments (AREA)

Abstract

Réacteur jetable (10) utilisé avec un instrument associé (20) de manière à former un dispositif analytique. Il comprend un corps de matière capillaire (14) placé dans une chambre (11, 15) dotée d'une ouverture permettant l'application d'un liquide sur le corps. Au moins un réactif (16) est immobilisé dans la chambre. En outre, un ensemble électrode (12, 12) traverse ladite chambre de sorte qu'une première partie de l'ensemble s'étende à l'intérieur de la chambre de manière qu'elle entre en contact avec le corps capillaire, et qu'une seconde partie s'étende à l'extérieur de la chambre à une certaine distance de l'ouverture de celle-ci, de manière qu'elle soit raccordée audit instrument associé.
PCT/GB1992/000576 1991-04-05 1992-04-01 Dispositifs analytiques Ceased WO1992017778A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4506950A JPH06506144A (ja) 1991-04-05 1992-04-01 分析装置

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9107193.6 1991-04-05
GB9107193A GB9107193D0 (en) 1991-04-05 1991-04-05 Analytical devices

Publications (1)

Publication Number Publication Date
WO1992017778A1 true WO1992017778A1 (fr) 1992-10-15

Family

ID=10692707

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1992/000576 Ceased WO1992017778A1 (fr) 1991-04-05 1992-04-01 Dispositifs analytiques

Country Status (5)

Country Link
EP (1) EP0578669A1 (fr)
JP (1) JPH06506144A (fr)
GB (2) GB9107193D0 (fr)
IE (1) IE921071A1 (fr)
WO (1) WO1992017778A1 (fr)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5628890A (en) * 1995-09-27 1997-05-13 Medisense, Inc. Electrochemical sensor
GB2365123A (en) * 2000-07-20 2002-02-13 Hypoguard Ltd Test strip
RU2205693C2 (ru) * 1998-06-30 2003-06-10 Ведалаб Устройство для определения анализируемого компонента в жидкой пробе
US6827899B2 (en) 2000-08-30 2004-12-07 Hypoguard Limited Test device
US6942769B2 (en) 2003-08-05 2005-09-13 Bt Medical Corp. Electrochemical sensor strip with low porosity screen
US7138089B2 (en) 2000-07-20 2006-11-21 Hypoguard Limited Test device for analyzing blood glucose or other analytes in bodily fluids
WO2007054850A3 (fr) * 2005-11-09 2007-09-27 Koninkl Philips Electronics Nv Dispositif pour controler un fluide
US7416699B2 (en) 1998-08-14 2008-08-26 The Board Of Trustees Of The Leland Stanford Junior University Carbon nanotube devices
WO2009027935A3 (fr) * 2007-08-31 2009-06-25 Koninkl Philips Electronics Nv Cartouche de capteur biochimique
US8550295B2 (en) 2010-02-22 2013-10-08 Roche Diagnostics Operations, Inc. Container for dispensing a single test strip
US9039974B2 (en) 2011-02-02 2015-05-26 Panasonic Healthcare Holdings Co., Ltd. Biological sample measuring device
WO2015136154A1 (fr) * 2014-03-13 2015-09-17 Kari Kolehmainen Bandelette d'essai et appareil de mesure du taux d'alcool ou d'une quelconque autre substance dans le sang et procédé de mesure du taux d'alcool dans le sang

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593852A (en) 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
WO1998035225A1 (fr) 1997-02-06 1998-08-13 E. Heller & Company DETECTEUR D'UN FAIBLE VOLUME D'ANALYTE $i(IN VITRO)
NZ524205A (en) * 1997-12-04 2004-05-28 Roche Diagnostics Corp Key mounting for biological measurement instrument
US6134461A (en) 1998-03-04 2000-10-17 E. Heller & Company Electrochemical analyte
US6103033A (en) 1998-03-04 2000-08-15 Therasense, Inc. Process for producing an electrochemical biosensor
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
JP3389106B2 (ja) * 1998-06-11 2003-03-24 松下電器産業株式会社 電気化学分析素子
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
CA2353670C (fr) * 1998-11-30 2010-08-10 Abbott Laboratories Dispositif de mesure multiproduits et bandelettes reactives
US6773671B1 (en) 1998-11-30 2004-08-10 Abbott Laboratories Multichemistry measuring device and test strips
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
USD914881S1 (en) 2003-11-05 2021-03-30 Abbott Diabetes Care Inc. Analyte sensor electronic mount
JP4717637B2 (ja) * 2004-01-07 2011-07-06 アークレイ株式会社 試薬部の配置を改良した分析用具および分析方法
WO2005089103A2 (fr) 2004-02-17 2005-09-29 Therasense, Inc. Procede et systeme de communication de donnees dans un systeme de controle et de gestion de glucose en continu
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
WO2010138856A1 (fr) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Systèmes d'antenne de dispositif médical comportant des configurations d'antenne externe
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
EP2473099A4 (fr) 2009-08-31 2015-01-14 Abbott Diabetes Care Inc Système de surveillance de substance à analyser et procédés de gestion de l'énergie et du bruit
WO2011041469A1 (fr) 2009-09-29 2011-04-07 Abbott Diabetes Care Inc. Procédé et appareil de fourniture de fonction de notification dans des systèmes de surveillance de substance à analyser
JP6443802B2 (ja) 2011-11-07 2018-12-26 アボット ダイアベティス ケア インコーポレイテッドＡｂｂｏｔｔ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｉｎｃ． 分析物モニタリング装置および方法
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
CA3050721A1 (fr) 2017-01-23 2018-07-26 Abbott Diabetes Care Inc. Systemes, dispositifs et procedes pour l'insertion de capteur d'analyte
JP2023540275A (ja) 2020-08-31 2023-09-22 アボット ダイアベティス ケア インコーポレイテッド 検体センサー挿入のためのシステム、装置、及び方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2127142A1 (de) * 1970-06-08 1971-12-16 Miles Lab Analysiergerät
EP0121385A1 (fr) * 1983-03-26 1984-10-10 Cambridge Life Sciences Plc Techniques biologiques de mesure conductométrique
EP0136362A1 (fr) * 1983-03-11 1985-04-10 Matsushita Electric Industrial Co., Ltd. Biocapteur
EP0230472A1 (fr) * 1985-06-21 1987-08-05 Matsushita Electric Industrial Co., Ltd. Capteur biologique et son procede de fabrication
EP0127958B1 (fr) * 1983-05-05 1992-03-11 MediSense, Inc. Electrodes pour des détecteurs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273639A (en) * 1979-06-20 1981-06-16 Eastman Kodak Company Capillary bridge in apparatus for determining ionic activity
US4549952A (en) * 1982-11-22 1985-10-29 Eastman Kodak Company Capillary transport device having means for increasing the viscosity of the transported liquid
DE3577748D1 (de) * 1984-06-13 1990-06-21 Unilever Nv Vorrichtungen zur verwendung in chemischen analyseverfahren.
EP0230645A3 (fr) * 1985-12-28 1987-12-09 Fuji Photo Film Co., Ltd. Appareil pour mesurer l'activité ionique
WO1988004048A1 (fr) * 1986-11-28 1988-06-02 Unilever N.V. Dispositifs et procedes de mesure electrochimique

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2127142A1 (de) * 1970-06-08 1971-12-16 Miles Lab Analysiergerät
EP0136362A1 (fr) * 1983-03-11 1985-04-10 Matsushita Electric Industrial Co., Ltd. Biocapteur
EP0121385A1 (fr) * 1983-03-26 1984-10-10 Cambridge Life Sciences Plc Techniques biologiques de mesure conductométrique
EP0127958B1 (fr) * 1983-05-05 1992-03-11 MediSense, Inc. Electrodes pour des détecteurs
EP0230472A1 (fr) * 1985-06-21 1987-08-05 Matsushita Electric Industrial Co., Ltd. Capteur biologique et son procede de fabrication

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5628890A (en) * 1995-09-27 1997-05-13 Medisense, Inc. Electrochemical sensor
RU2205693C2 (ru) * 1998-06-30 2003-06-10 Ведалаб Устройство для определения анализируемого компонента в жидкой пробе
US7416699B2 (en) 1998-08-14 2008-08-26 The Board Of Trustees Of The Leland Stanford Junior University Carbon nanotube devices
GB2365123A (en) * 2000-07-20 2002-02-13 Hypoguard Ltd Test strip
US7138089B2 (en) 2000-07-20 2006-11-21 Hypoguard Limited Test device for analyzing blood glucose or other analytes in bodily fluids
US6827899B2 (en) 2000-08-30 2004-12-07 Hypoguard Limited Test device
US6942769B2 (en) 2003-08-05 2005-09-13 Bt Medical Corp. Electrochemical sensor strip with low porosity screen
WO2007054850A3 (fr) * 2005-11-09 2007-09-27 Koninkl Philips Electronics Nv Dispositif pour controler un fluide
US7955558B2 (en) 2005-11-09 2011-06-07 Koninklijke Philips Electronics N.V. Device for testing a fluid
WO2009027935A3 (fr) * 2007-08-31 2009-06-25 Koninkl Philips Electronics Nv Cartouche de capteur biochimique
US8550295B2 (en) 2010-02-22 2013-10-08 Roche Diagnostics Operations, Inc. Container for dispensing a single test strip
US9039974B2 (en) 2011-02-02 2015-05-26 Panasonic Healthcare Holdings Co., Ltd. Biological sample measuring device
WO2015136154A1 (fr) * 2014-03-13 2015-09-17 Kari Kolehmainen Bandelette d'essai et appareil de mesure du taux d'alcool ou d'une quelconque autre substance dans le sang et procédé de mesure du taux d'alcool dans le sang

Also Published As

Publication number Publication date
GB2254436A (en) 1992-10-07
IE921071A1 (en) 1992-10-07
GB2254436B (en) 1994-08-17
GB9107193D0 (en) 1991-05-22
JPH06506144A (ja) 1994-07-14
EP0578669A1 (fr) 1994-01-19
GB9207169D0 (en) 1992-05-13

Similar Documents

Publication Publication Date Title
WO1992017778A1 (fr) Dispositifs analytiques
US4356074A (en) Substrate specific galactose oxidase enzyme electrodes
EP1036320B1 (fr) Bandelettes reactives de biodetection electrochimique ameliorees
US5217594A (en) Convenient determination of trace lead in whole blood and other fluids
US6942770B2 (en) Disposable sub-microliter volume biosensor with enhanced sample inlet
EP0636879B1 (fr) Méthode pour la production d'un biocapteur
US6258229B1 (en) Disposable sub-microliter volume sensor and method of making
JP2838484B2 (ja) ガス測定用バイオセンサー及びその製造方法
JP2001208716A (ja) 微小球含有センサー
JP2002514744A5 (fr)
AU5387286A (en) Electrochemical assay for cis-diols
JPH08511942A (ja) 診断用試薬安定剤
CA2543010A1 (fr) Biocapteur electrochimique enzymatique
DE69809391D1 (de) Kleinvolumiger sensor zur in-vitro bestimmung
CA2346415A1 (fr) Detecteur d'analytes in vitro dans de petits volumes utilisant un mediateur diffusible ou non lixiviable
JPH09500727A (ja) 電位差式バイオセンサー及びその使用方法
US3654180A (en) Indicator for detecting hydrogen peroxide and peroxidative compounds containing alpha naphthoflavone
JP3477511B2 (ja) 金白金電極を用いたバイオセンサ
JPS6257942B2 (fr)
JPH0810207B2 (ja) バイオセンサ
Wolff et al. Nonmembrane amperometric sensor for dissolved oxygen in flow-through systems
JPS58216947A (ja) スクロ−ス濃度測定用酵素電極
AU2006202499B2 (en) Improved electrochemical biosensor test strip
AU2005202280B2 (en) Improved electrochemical biosensor test strip
AU755187B2 (en) Improved electrochemical biosensor test strip

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref country code: US

Ref document number: 1993 129112

Date of ref document: 19931005

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1992907175

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1992907175

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1992907175

Country of ref document: EP